Catalyst Wire Dossier Catalyst Wire Dossier

PSA-NCAM(+) Neural Progenitor Cell transplantation

PSA-NCAM positive neural progenitor cells · S.Biomedics Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PSA-NCAM(+) Neural Progenitor Cell transplantation, covering 2025-05-18 to 2025-05-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI [Phase 1, Phase 2]

See pricing